- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/761 - Adenovirus
Patent holdings for IPC class A61K 35/761
Total number of patents in this class: 1038
10-year publication summary
|
33
|
47
|
86
|
104
|
119
|
101
|
127
|
76
|
88
|
48
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Trustees of the University of Pennsylvania | 4326 |
43 |
| Akamis Bio Limited | 58 |
30 |
| The Regents of the University of California | 19989 |
22 |
| The Salk Institute for Biological Studies | 445 |
20 |
| Takeda Pharmaceutical Company Limited | 2711 |
17 |
| Genemedicine Co., Ltd. | 31 |
17 |
| Psioxus Therapeutics Limited | 27 |
16 |
| University of Florida Research Foundation, Inc. | 4037 |
14 |
| City of Hope | 994 |
14 |
| Tilt Biotherapeutics Oy | 27 |
14 |
| Adverum Biotechnologies, Inc. | 93 |
13 |
| Epicentrx, Inc. | 90 |
13 |
| Mayo Foundation for Medical Education and Research | 3225 |
12 |
| Hangzhou Converd Co., Ltd. | 34 |
11 |
| Janssen Vaccines & Prevention B.V. | 310 |
11 |
| Centre National de La Recherche Scientifique | 10465 |
9 |
| Research Institute at Nationwide Children's Hospital | 560 |
9 |
| Beth Israel Deaconess Medical Center, Inc. | 857 |
8 |
| Homology Medicines, Inc. | 47 |
8 |
| Kagoshima University | 310 |
7 |
| Other owners | 730 |